Related Experiment Video
Updated: May 1, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Wikstroelide M potently inhibits HIV replication by targeting reverse transcriptase and integrase nuclear
Xuan Zhang1, Sheng-Zhuo Huang2, Wan-Gang Gu3
1Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research of Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China; School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China.
Wikstroelide M demonstrates potent anti-HIV activity against HIV-1 and HIV-2 strains. Its mechanism involves inhibiting reverse transcriptase and integrase nuclear translocation by disrupting LEDGF/p75 interaction.
Area of Science:
- Natural Product Chemistry
- Virology
- Medicinal Chemistry
Background:
- Human Immunodeficiency Virus (HIV) remains a significant global health challenge.
- Daphne acutiloba Rehder is a traditional medicinal plant with potential therapeutic compounds.
- Daphnane diterpenes represent a class of natural products with diverse biological activities.
Purpose of the Study:
- To investigate the anti-HIV activity of wikstroelide M, a daphnane diterpene isolated from Daphne acutiloba.
- To elucidate the mechanism of action of wikstroelide M against HIV infection.
Main Methods:
- Cytopathic effect and p24 quantification assays were used to evaluate anti-HIV activity against various HIV strains.
- Real-time PCR and ELISA were employed to analyze the inhibition of HIV reverse transcription.
- Cell-based imaging and molecular docking were utilized to study HIV-1 integrase nuclear translocation and LEDGF/p75-IN interaction.
Main Results:
- Wikstroelide M exhibited potent inhibition against multiple HIV-1 and HIV-2 strains, with EC50 values in the ng·mL⁻¹ range.
- The compound effectively inhibited HIV-1IIIB induced cytolysis in MT-4 cells.
- Mechanistic studies revealed that wikstroelide M targets HIV-1 reverse transcriptase and integrase nuclear translocation by disrupting the LEDGF/p75-integrase interaction.
Conclusions:
- Wikstroelide M is a promising inhibitor of both HIV-1 and HIV-2.
- The anti-HIV mechanisms include the inhibition of reverse transcriptase activity and integrase nuclear translocation.
- Disruption of the LEDGF/p75-integrase interaction is a key aspect of wikstroelide M's antiviral action.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
12:03Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Related Concept Videos
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis
Size and Structure of Viral Genomes
Viruses with RNA Genomes
Sexually Transmitted Infections
Inhibition of CDK Activity